The diagnosis of NLE liver disease requires that bilirubin and liver enzyme levels are consistent with cholestasis and hepatitis, along with detection in the infant of maternal antibodies to SSA/Ro and/or SSB/La. This evidence concerns the gene CALR and Hepatitis.